FDA Releases Guidance on Institutional Review Board Review of HIPAA Authorizations

Summary

The FDA has made available a document clarifying the responsibilities of institutional review boards (IRBs) in reviewing and approving stand-alone HIPAA authorizations, which allow covered entities to use and disclose individual health information for research studies without prior IRB review and approval.